Mr Mark Anthony Schiffner, PA-C | |
90 Riverside Dr, North Bennington, VT 05257-9666 | |
(802) 442-9597 | |
Not Available |
Full Name | Mr Mark Anthony Schiffner |
---|---|
Gender | Male |
Speciality | Physician Assistant - Medical |
Location | 90 Riverside Dr, North Bennington, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790757532 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363AM0700X | Physician Assistant - Medical | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Mark Anthony Schiffner, PA-C 90 Riverside Dr, North Bennington, VT 05257-9666 Ph: (802) 442-9597 | Mr Mark Anthony Schiffner, PA-C 90 Riverside Dr, North Bennington, VT 05257-9666 Ph: (802) 442-9597 |
News Archive
Health Sciences Group, Inc. would like to announce that it has completed a licensing agreement with The Healing Center of Montana for the territory of Livingston County, Montana for purposes of operating a medical marijuana collective and distribution center for medical marijuana patients as pertains to Montana state and Livingston County law.
Vitamin Shoppe, Inc. today announced that the public offering of 6,236,320 shares of its common stock has priced at $23.50 per share. All of the shares of common stock are being sold by certain stockholders of Vitamin Shoppe. The underwriters have a 30-day option to purchase up to an additional 935,448 shares from the selling stockholders.
Mutations in a group of genes associated with brain activity frequently cause intellectual disability, according to a study led by scientists affiliated with the University of Montreal and the research centre at the Centre hospitalier universitaire Sainte-Justine. Intellectual disability is a severe handicap that affects between one and two percent of children worldwide. It can often be attributed to genetic causes, but the specific genes involved were mostly unknown.
In a recently published article scientists have provided a detailed description of the utility of mannose-specific lectins in preventing coronavirus infections. They have specifically explained how mannose-specific lectins derived from plants, algae, fungi, and bacteria selectively bind N-glycans present on the surface of viral spike protein and how such interactions can be medically utilized to control coronavirus transmission.
› Verified 5 days ago